LYRCX
Price
$32.47
Change
-$0.47 (-1.43%)
Updated
Aug 31 closing price
Net Assets
1.33B
VMVAX
Price
$106.61
Change
-$0.36 (-0.34%)
Updated
Sep 1 closing price
Net Assets
38.61B
Interact to see
Advertisement

LYRCX vs VMVAX

LYRCX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 38.6B vs. LYRCX (1.33B). VMVAX pays higher dividends than LYRCX: VMVAX (1.79) vs LYRCX (0.00). LYRCX was incepted earlier than VMVAX: LYRCX (4 years) vs VMVAX (15 years). LYRCX (2.56) is less costly to investors than VMVAX (0.07). LYRCX is a more actively managed with annual turnover of: 32.00 vs. VMVAX (23.00). LYRCX has a lower initial minimum investment than VMVAX: LYRCX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 20.38 vs. LYRCX (12.63).
LYRCXVMVAXLYRCX / VMVAX
Total Expense Ratio1.990.072,843%
Annual Report Gross Expense Ratio2.560.073,657%
Fund Existence4 years15 years-
Gain YTD16.88017.25498%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B38.6B3%
Annual Yield % from dividends0.001.79-
Returns for 1 year12.6320.3862%
Returns for 3 years60.1351.09118%
Returns for 5 yearsN/A44.28-
Returns for 10 yearsN/A124.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRCOX74.66N/A
N/A
T. Rowe Price U.S. Equity Research R
GPGIX4.01N/A
N/A
Grandeur Peak Global Opportunities Instl
GQRRX18.67N/A
N/A
GQG Partners Global Quality Equity R6
VEILX17.34N/A
N/A
VELA International A
OAKGX42.88-0.20
-0.46%
Oakmark Global Investor